SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Sophia Genetics

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma companies CHICAGO, November 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and …

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Read More »

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance

Sophia Genetics

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enroll 4,000 patients from approximately 30 sites across North America, Europe, and Latin America BOSTON and LAUSANNE, Switzerland, December 1, …

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance Read More »

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Sophia Genetics

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma companies CHICAGO, November 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and …

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Read More »

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance

Sophia Genetics

Third quarter year-over-year revenue growth of 45%; executed Master Alliance Agreement with GE Healthcare BOSTON and LAUSANNE, Switzerland, November 10, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent Highlights Revenue was $10.4 million for the third quarter, representing a 45% increase over the corresponding …

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance Read More »

NetGuardians named as AITE global leader in machine learning fraud prevention and anti money laundering

NetGuardians

NetGuardians was today named as a global leader in AITE’s 2021 Fraud and AML Machine Learning Platforms Report. The Swiss fintech was ranked best in class for client strength, which takes into account the total number of machine learning instances in production, the client retention rate and the vendor’s reputation. It also scored highly for …

NetGuardians named as AITE global leader in machine learning fraud prevention and anti money laundering Read More »

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

Sophia Genetics

BOSTON and LAUSANNE, Switzerland, January 10, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief BioPharma Officer and Abhimanyu (Abhi) Verma as Chief Technology Officer. The additions are part of SOPHiA GENETICS’ …

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business Read More »

2021 IN REVIEW

Cysec

“Another extraordinary year marked by the pandemic is behind us, so I hope that my season greetings find you all in good health. Despite the continuous uncertainty, CYSEC had the chance to grow and develop its business successfully in 2021, so it is time for us to show gratitude to colleagues, clients, partners and investors. …

2021 IN REVIEW Read More »

CYSEC ARCA – AMD-SEV – WHITEPAPER

Cysec

INTRODUCTIONEnterprises are accelerating their migration to digitalization and to adopting cloud-based services but remain reluctant to move sensitive and mission-critical data and workloads onto the cloud because of concerns that include. Integrity and confidentiality of data, particularly while that data is in use Ownership and management of the security and encryption keys Cloud provider access …

CYSEC ARCA – AMD-SEV – WHITEPAPER Read More »